Cite
HARVARD Citation
Yang, M. et al. (2023). Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial. BMJ open. 13 (2), p. . [Online].